National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Northrop Grumman Corporation, Atlanta, GA, USA.
Vaccine. 2019 Jan 29;37(5):686-689. doi: 10.1016/j.vaccine.2018.12.023. Epub 2018 Dec 24.
In the United States, human papillomavirus (HPV) vaccine has been recommended for females since 2006 and for males since 2011. However, national HPV vaccination coverage among adolescents is lower than national targets, and many adolescents initiate HPV vaccination later than the recommended age. We analyzed records for >2 million persons born during 1996-2000 who initiated HPV vaccination at age 9 through 16 years from six Immunization Information Systems Sentinel Sites, displayed the distribution of HPV vaccination initiation age, and calculated HPV vaccination coverage. More adolescents in recent cohorts initiated HPV vaccination at the recommended age of 11-12 years, the majority of whom received another recommended vaccine on the same day. However, >40% of all vaccinated adolescents did not initiate the HPV vaccination until age 13 years or later. Continued efforts are needed to increase HPV vaccination initiation at the recommended age.
在美国,自 2006 年以来,人乳头瘤病毒(HPV)疫苗已被推荐用于女性,自 2011 年以来已被推荐用于男性。然而,青少年的全国 HPV 疫苗接种率低于国家目标,许多青少年接种 HPV 疫苗的年龄晚于推荐年龄。我们分析了六个免疫信息系统监测点超过 200 万名在 1996-2000 年期间出生的人的记录,这些人在 9-16 岁时开始接种 HPV 疫苗,并展示了 HPV 疫苗接种起始年龄的分布情况,并计算了 HPV 疫苗接种率。最近几批青少年中,更多人在推荐的 11-12 岁年龄开始接种 HPV 疫苗,其中大多数人在同一天还接种了另一种推荐疫苗。然而,超过 40%的所有接种疫苗的青少年直到 13 岁或更晚才开始接种 HPV 疫苗。需要继续努力,以增加在推荐年龄开始接种 HPV 疫苗。